NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

細胞治療藥物包裝產品/服務市場

Cell Therapy Packaging Products and Services Market by Type of Therapy (T-cell Therapies, Dendritic Cell Vaccines, Stem Cell Therapies, NK Cell Therapies and Other ATMPs), Package Engineering Design (Primary and Secondary Packaging),

出版商 Roots Analysis 商品編碼 1024363
出版日期 內容資訊 英文 180 Pages
商品交期: 最快1-2個工作天內
價格
細胞治療藥物包裝產品/服務市場 Cell Therapy Packaging Products and Services Market by Type of Therapy (T-cell Therapies, Dendritic Cell Vaccines, Stem Cell Therapies, NK Cell Therapies and Other ATMPs), Package Engineering Design (Primary and Secondary Packaging),
出版日期: 2021年06月30日內容資訊: 英文 180 Pages
簡介

細胞治療藥物和基因治療藥物等先進醫療藥物 (ATMP) 改變了醫療方式,因為它們可以處理廣泛的症狀。目前,已有30餘種細胞治療藥物在各地獲批上市,1000餘種治療候選藥物正在臨床評價中。

由於成本高、需要特殊設備以及處理細胞治療產品的複雜性,醫療行業的創新者在藥品製造、包裝和運輸要求方面涉及合同服務提供商,這是有可能的。隨著時間的推移,世界各地的監管機構,如美國食品和藥物管理局 (FDA) 和國際航空運輸協會 (IATA),都制定了有關包裝、儲存和運輸細胞治療藥物的指南。

本報告調查和分析全球細胞治療包裝產品/服務市場,並提供有關當前市場規模和未來潛力的系統信息。

目錄

第一章前言

第 2 章執行摘要

第 3 章介紹

第四章細胞治療藥物包裝服務商:市場現狀

  • 章節概述
  • 細胞治療藥物包裝服務商市場情況

第5章細胞治療藥物包裝產品供應商:市場現狀

  • 章節概述
  • 細胞治療藥物包裝產品:市場現狀
  • 細胞治療藥物包裝產品供應商

第六章細胞治療藥物包裝服務/產品供應商:企業簡介

  • 章節概述
  • 細胞治療藥物包裝服務商
    • 阿爾馬克
    • 康泰倫特製藥解決方案
    • 冷凍端口系統
    • 你的方式
  • 細胞治療藥物包裝產品供應商
    • 漢莎貨運
    • 聖戈班生命科學
    • 賽默飛世爾科技
    • 西藥服務

第七章企業競爭力分析

  • 章節概述
  • 方法和關鍵輸入參數
  • 細胞治療藥物包裝服務商

第 8 章夥伴關係和協作

  • 章節概述
  • 合作模式
  • 細胞治療藥物包裝:夥伴關係和合作清單

第9章潛在合作夥伴分析

  • 章節概述
  • 範圍和方法
  • 北美細胞治療包裝供應商的潛在戰略合作夥伴
  • 歐洲細胞療法包裝供應商的潛在戰略合作夥伴
  • 亞太地區和其他地區細胞療法包裝供應商的潛在戰略合作夥伴

第 10 章細胞治療藥物開發商/製造商:案例研究

  • 章節概述
  • 細胞治療藥物廠商:整體市場情況

第11章市場規模和機會分析

  • 章節概述
  • 主要前提和預測方法
  • 全球細胞治療藥物包裝服務市場
  • 細胞治療藥物包裝服務市場:細胞治療藥物按類型分佈
  • 細胞治療藥物包裝服務市場:按包裝工程設計分佈
  • 細胞治療藥物包裝服務市場:按業務規模分佈
  • 細胞治療藥物包裝服務市場:按地區分佈

第12章結論

第十三章附錄1:表格數據

第 14 章附錄 2:公司/組織名單

目錄

Title:
Cell Therapy Packaging Products and Services Market
by Type of Therapy (T-cell Therapies, Dendritic Cell Vaccines, Stem Cell Therapies, NK Cell Therapies and Other ATMPs), Package Engineering Design (Primary and Secondary Packaging), Scale of Operation (Clinical and Commercial) and Geography (North America, Europe, Asia Pacific and Rest of the World): Industry Trends and Global Forecasts, 2021-2030.

Overview:

Given their ability to treat a wide range of clinical conditions, advanced therapy medicinal products, including cell and gene therapies, have revolutionized the delivery of healthcare. Presently, more than 30 cell-based therapy products have received marketing approvals across various geographies, while more than 1,000 therapeutic candidates are under clinical evaluation. Considering the lucrative investment opportunity within this domain, several investors are actively supporting ongoing / future product development programs in this upcoming field of pharmacological interventions. In fact, there has been a 240% increase in investment activity, in terms of capital amount invested, between 2019 and 2020. However, the ultimate success of cell therapies is dependent on the safe and timely delivery of viable doses of therapeutic cells to the right patient. In this context, it is worth highlighting that drug product manufacturing, packaging and logistics operations involving cell therapies are both complex and challenging. Moreover, in order to ensure the stability of such products across the supply chain, specific temperature conditions (cryogenic, ambient or refrigerated) are required, in addition to specialized packaging material. Considering that most cell therapies are personalized, it is imperative that errors in labeling are avoided at all costs.

Given the need for costly and specialized equipment and the complexities associated with handling cell-based therapy products, innovators in the healthcare industry are likely to involve contract service providers for their drug product production, packaging and transportation requirements. Over time, regulators across the world, including the US Food and Drug Administration (FDA) and the International Air Transport Association (IATA), have established guidelines for the packaging, storage and transport of cell therapies. Since CMOs / CDMOs with the necessary capabilities to handle cell therapies are also likely to have established processes that comply with the current acceptable standards across different global regions, it is better for therapy developers to strategically partner with the aforementioned players instead of focusing on developing in-house capabilities. Presently, close to 60 companies claim to be offering cell therapy packaging services and associated products. In fact, it is estimated that close to 30% of drug substance and drug product related operations of advanced therapy medicinal products are already outsourced to capable CMOs / CDMOs. Further, over the last few years, several service providers have also forged strategic alliances among themselves, in order to further expand existing capabilities and augment their respective service offerings. Given the rising trend of outsourcing in the healthcare industry, and the ongoing efforts of service providers to further improve their portfolios, we believe that the cell therapy packaging products and services market is likely to evolve at a steady pace in the next few years.

Scope of the Report:

The "Cell Therapy Packaging Products and Services Market by Type of Therapy (T-cell Therapies, Dendritic Cell Vaccines, Stem Cell Therapies, NK Cell Therapies and Other ATMPs), Package Engineering Design (Primary and Secondary Packaging), Scale of Operation (Clinical and Commercial) and Geography (North America, Europe, Asia Pacific and Rest of the World) , 2021-2030" report features an elaborate study of the current scenario and future opportunity within the cell therapy packaging products and services market. In addition, the report features an in-depth analysis, highlighting the diverse capabilities of stakeholders engaged in this domain. Amongst other elements, the report includes:

  • An overview of the current market landscape of cell therapy packaging services providers, including a detailed analysis based on their year of establishment, company size, location of headquarters, package engineering design (primary and secondary) , type of packaging (active and passive) , packaging material (dry ice and liquid nitrogen) , type of passive system used, temperature ranges supported, type of cells handled and additional services offered.
  • A detailed assessment of the current market landscape of cell therapy packaging products, providing information on type of packaging container (bags, vials, shipping container and others) , container fabrication material (plastic and others) , storage temperature conditions, type of cells packed and usability of containers. In addition, the chapter highlights analysis of cell therapy packaging product provider(s), based on various parameters such as year of establishment, company size and location of headquarters and key players.
  • An in-depth competitiveness analysis of cell therapy packaging service providers based in different geographies, by taking into consideration the service strength of a company (based on its experience), packaging portfolio (package engineering design, type of packaging, type of packaging material and temperature ranges supported) service portfolio (type of additional services offered) and company size (small, mid-sized and large companies) .
  • An analysis of the various partnerships established between cell therapy packaging providers and cell therapy developers, during the period, 2016-2021. It includes a brief description of various types of partnership models (namely service alliance, technology / platform integration agreement, merger and acquisition) adopted by stakeholders engaged in this domain. It is worth mentioning that the data captured during our research was analyzed based on several parameters, such as year of partnership, type of partnership, purpose of partnership, type of service covered and geographical location of players involved in a partnership.
  • A list of more than 250 cell therapy developers anticipated to partner with cell therapy packaging providers, which have been shortlisted on the basis of developer strength (based on company size), type of therapy and pipeline maturity (based on stage of development of drug candidate) .
  • A case study highlighting the companies that claim to have the required expertise and capabilities for development and manufacturing of cell therapies, along with the information on their year of establishment, company size, location of headquarters and location of manufacturing facility. In addition, the chapter presents analysis on type of cells manufactured, source of cells, scale of operation and manufacturing capabilities / services of the aforementioned companies.
  • Detailed profiles of the key players offering cell therapy packaging services and products. Each profile includes a brief overview of the company, details on cell therapy service portfolio, information on cell therapy packaging product portfolio, recent developments and an informed future outlook.

One of the key objectives of the report was to estimate the existing market size and future growth potential of the cell therapy packaging providers market. We have provided informed estimates on the likely evolution of the market in the short to mid-term and long term, for the period 2021-2030. Our year-wise projections of the current and future opportunity have further been segmented across [A] type of therapy (T-cell therapies, dendritic cell vaccines, stem cell therapies, NK cell therapies and other advanced therapy medicinal products), [B] package engineering design (primary and secondary packaging), [C] scale of operation (clinical and commercial) and [D] geography (North America, Europe, Asia Pacific and Rest of the World)

All actual figures have been sourced and analyzed from publicly available information forums. Financial figures mentioned in this report are in USD, unless otherwise specified.

Key Questions Answered:

  • Who are the leading players offering cell therapy packaging services and products?
  • What are the key considerations and challenges associated with cell therapy packaging?
  • Which partnership models are commonly adopted by stakeholders engaged in this industry?
  • Which players are likely to partner with cell therapy packaging service and product providers?
  • What factors are likely to influence the evolution of the cell therapy packaging service providers market?
  • What are the likely future trends in cell therapy packaging services market?
  • How is the current and future opportunity likely to be distributed across key market segments?

Chapter Outlines:

Chapter 2 is an executive summary of the key insights captured in our research. It offers a high-level view on the current state of cell therapy packaging providers market and its likely evolution in the short-mid to long term.

Chapter 3 provides a general introduction to the pharmaceutical filling and packaging, including information on types of pharmaceutical packaging. The chapter lays emphasis on cell therapy packaging, primary and secondary packaging of cell therapies. In addition, it discusses the key considerations and challenges associated with cell therapy packaging.

Chapter 4 features an overview of the current market landscape of cell therapy packaging services providers, including a detailed analysis on the year of establishment, company size and location of headquarters. In addition, the chapter highlights the analysis on the package engineering design (primary and secondary), type of packaging (active and passive), packaging material (dry ice and liquid nitrogen) and type of passive system used. Further, the chapter also presents analysis on temperature ranges supported, type of cells handled and additional services offered.

Chapter 5 presents a detailed assessment of the current market landscape of cell therapy packaging products, providing information on type of packaging container (bags, vials, shipping container and others), container fabrication material (plastic and others), storage temperature conditions, type of cells packed and usability of containers. In addition, the chapter highlights analysis of cell therapy packaging product provider(s), based on various parameters such as year of establishment, company size and location of headquarters and key players.

Chapter 6 includes profiles of the key players offering cell therapy packaging services and products. Each profile includes a brief overview of the company, details on cell therapy service portfolio, information on cell therapy packaging product portfolio, recent developments and an informed future outlook.

Chapter 7 presents in-depth competitiveness analysis of cell therapy packaging service providers based in different geographies, by taking into consideration the service strength of a company (based on its experience), packaging portfolio (package engineering design, type of packaging, type of packaging material and temperature ranges supported) service portfolio (type of additional services offered) and company size (small, mid-sized and large companies).

Chapter 8 provides an analysis of the various partnerships established between cell therapy packaging providers and cell therapy developers, during the period, 2016-2021. It includes a brief description of various types of partnership models (namely service alliance, technology / platform integration agreement, merger and acquisition) adopted by stakeholders engaged in this domain. It is worth mentioning that the data captured during our research was analyzed based on several parameters, such as year of partnership, type of partnership, purpose of partnership, type of service covered and geographical location of players involved in a partnership.

Chapter 9 presents a list of more than 250 cell therapy developers anticipated to partner with cell therapy packaging providers, which have been shortlisted on the basis of developer strength (based on company size), type of therapy and pipeline maturity (based on stage of development of drug candidate).

Chapter 10 features a case study highlighting the companies that claim to have the required expertise and capabilities for development and manufacturing of cell therapies, along with the information on their year of establishment, company size, location of headquarters and location of manufacturing facility. In addition, the chapter presents analysis on type of cells manufactured, source of cells, scale of operation and manufacturing capabilities / services of the aforementioned companies.

Chapter 11 presents a detailed market forecast analysis, providing insights on the likely growth of continuous manufacturing equipment providers market for the period 2021-2030. In addition, the chapter presents the likely distribution of the projected future opportunity based on type of therapy (T-cell therapies, dendritic cell vaccines, stem cell therapies, NK cell therapies and other advanced therapy medicinal products), package engineering design (primary and secondary packaging), scale of operation (clinical and commercial) and geography (North America, Europe, Asia Pacific and Rest of the World).

Chapter 12 is a summary of the overall report, which presents the insights on the contemporary market trends and the likely evolution of cell therapy products and services market.

Chapter 13 is an appendix that contains tabulated data and numbers for all the figures provided in the report.

Chapter 14 is an appendix that provides the list of companies and organizations mentioned in the report.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Scope of the Report
  • 1.2. Research Methodology
  • 1.3. Key Questions Answered
  • 1.4. Chapter Outlines

2. EXECUTIVE SUMMARY

3. INTRODUCTION

  • 3.1. Chapter Overview
  • 3.2. Pharmaceutical Filling and Packaging
  • 3.3. Importance of Pharmaceutical Packaging
  • 3.4. Types of Pharmaceutical Packaging
  • 3.5. Packaging of Cell Therapies
    • 3.5.1. Primary Packaging
    • 3.5.2. Secondary Packaging
  • 3.6. Cell Therapy Packaging: Key Considerations
  • 3.7. Challenges associated with Cell Therapy Packaging
  • 3.8. Concluding Remarks

4. CELL THERAPY PACKAGING SERVICE PROVIDERS: MARKET LANDSCAPE

  • 4.1. Chapter Overview
  • 4.2. Cell Therapy Packaging Service Providers Market Landscape
    • 4.2.1. Analysis by Year of Establishment
    • 4.2.2. Analysis by Company Size
    • 4.2.3. Analysis by Location of Headquarters
    • 4.2.4. Analysis by Package Engineering Design
    • 4.2.5. Analysis by Type of Packaging
    • 4.2.6. Analysis by Type of Packaging Material
    • 4.2.7. Analysis by Type of Passive System Used
    • 4.2.8. Analysis by Temperature Ranges Supported
    • 4.2.9. Analysis by Type of Cells Handled
    • 4.2.10. Analysis by Type of Additional Service(s) Offered
    • 4.2.11. Logo Landscape: Key Players offering Additional Services

5. CELL THERAPY PACKAGING PRODUCT PROVIDERS: MARKET LANDSCAPE

  • 5.1. Chapter Overview
  • 5.2. Cell Therapy Packaging Products: Market Landscape
    • 5.2.1. Analysis by Type of Packaging Container
    • 5.2.2. Analysis by Container Fabrication Material
    • 5.2.3. Analysis by Type of Packaging Container and Container Fabrication Material
    • 5.2.4. Analysis by Storage Temperature Conditions
    • 5.2.5. Analysis by Type of Packaging Container and Storage Temperature Conditions
    • 5.2.6. Analysis by Type of Cells Packed
    • 5.2.7. Analysis by Usability of Container
  • 5.3. Cell Therapy Packaging Product Providers
    • 5.3.1. Analysis by Year of Establishment
    • 5.3.2. Analysis by Company Size
    • 5.3.3. Analysis by Location of Headquarters

6. CELL THERAPY PACKAGING SERVICE AND PRODUCT PROVIDERS: COMPANY PROFILES

  • 6.1. Chapter Overview
  • 6.2 Cell Therapy Packaging Service Providers
    • 6.2.1. Almac
      • 6.2.1.1. Company Overview
      • 6.2.1.2. Cell Therapy Service Portfolio
      • 6.2.1.3. Recent Developments and Future Outlook
    • 6.2.2. Catalent Pharma Solutions
      • 6.2.2.1. Company Overview
      • 6.2.2.2. Cell Therapy Service Portfolio
      • 6.2.2.3. Recent Developments and Future Outlook
    • 6.2.3. Cryoport Systems
      • 6.2.3.1. Company Overview
      • 6.2.3.2. Cell Therapy Service Portfolio
      • 6.2.3.3. Recent Developments Future Outlook
    • 6.2.4. Yourway
      • 6.2.4.1. Company Overview
      • 6.2.4.2. Cell Therapy Service Portfolio
      • 6.2.4.3. Recent Developments and Future Outlook
  • 6.3. Cell Therapy Packaging Product Providers
    • 6.3.1. Lufthansa Cargo
      • 6.3.1.1. Company Overview
      • 6.3.1.2. Cell Therapy Packaging Product Portfolio
      • 6.3.1.3. Recent Developments and Future Outlook
    • 6.3.2. Saint-Gobain Life Sciences
      • 6.3.2.1. Company Overview
      • 6.3.2.2. Cell Therapy Packaging Product Portfolio
      • 6.3.2.3. Recent Developments and Future Outlook
    • 6.3.3. Thermo Fisher Scientific
      • 6.3.3.1. Company Overview
      • 6.3.3.2. Cell Therapy Packaging Product Portfolio
      • 6.3.3.3. Recent Developments and Future Outlook
    • 6.3.4. West Pharmaceutical Services
      • 6.3.4.1. Company Overview
      • 6.3.4.2. Cell Therapy Packaging Product Portfolio
      • 6.3.4.3. Recent Developments and Future Outlook

7. COMPANY COMPETITIVENESS ANALYSIS

  • 7.1. Chapter Overview
  • 7.2. Methodology and Key Input Parameters
  • 7.3. Cell Therapy Packaging Service Providers
    • 7.3.1. Companies based in North America
    • 7.3.2. Companies based in Europe and Asia Pacific

8. PARTNERSHIPS AND COLLABORATIONS

  • 8.1. Chapter Overview
  • 8.2. Partnership Models
  • 8.3. Cell Therapy Packaging: List of Partnerships and Collaborations
    • 8.3.1. Analysis by Year of Partnership
    • 8.3.2. Analysis by Type of Partnership
    • 8.3.3. Analysis by Year and Type of Partnership
    • 8.3.4. Analysis by Purpose of Partnership
    • 8.3.5. Analysis by Type of Service(s) Covered
    • 8.3.6. Most Active Players: Analysis by Number of Partnerships
    • 8.3.7. Regional Analysis
    • 8.3.8. Intercontinental and Intracontinental Agreements

9. LIKELY PARTNER ANALYSIS

  • 9.1. Chapter Overview
  • 9.2. Scope and Methodology
  • 9.3. Potential Strategic Partners for Cell Therapy Packaging Providers in North America
    • 9.3.1. Most Likely Partners
    • 9.3.2. Likely Partners
    • 9.3.3. Less Likely Partners
  • 9.4. Potential Strategic Partners for Cell Therapy Packaging Providers in Europe
    • 9.4.1. Most Likely Partners
    • 9.4.2. Likely Partners
    • 9.4.3. Less Likely Partners
  • 9.5. Potential Strategic Partners for Cell Therapy Packaging Providers in Asia Pacific and Rest of the World
    • 9.5.1. Most Likely Partners
    • 9.5.2. Likely Partners
    • 9.5.3. Less Likely Partners

10. CELL THERAPY DEVELOPERS AND MANUFACTURERS: CASE STUDY

  • 10.1. Chapter Overview
  • 10.2. Cell Therapy Manufacturers: Overall Market Landscape
    • 10.2.1. Analysis by Year of Establishment
    • 10.2.2. Analysis by Company Size
    • 10.2.3. Analysis by Location of Headquarters
    • 10.2.4. Analysis by Location of Manufacturing Facility
    • 10.2.5. Analysis by Type of Cell(s) Manufactured
    • 10.2.6. Analysis by Source of Cells
    • 10.2.7. Analysis by Scale of Operation
    • 10.2.8. Analysis by Manufacturing Capabilities / Services
    • 10.2.9. Concluding Remarks

11. MARKET SIZING AND OPPORTUNITY ANALYSIS

  • 11.1. Chapter Overview
  • 11.2. Key Assumptions and Forecast Methodology
  • 11.3 Global Cell Therapy Packaging Services Market, 2021-2030
  • 11.4 Cell Therapy Packaging Services Market, 2021-2030: Distribution by Type of Cell Therapy
    • 11.4.1. Cell Therapy Packaging Services Market for T-Cell Therapies, 2021-2030
    • 11.4.2. Cell Therapy Packaging Services Market for Dendritic Cell Vaccines, 2021-2030
    • 11.4.3. Cell Therapy Packaging Services Market for Stem Cell Therapies, 2021-2030
    • 11.4.4. Cell Therapy Packaging Services Market for NK Cell Therapies, 2021-2030
    • 11.4.5. Cell Therapy Packaging Services Market for Other Advanced Therapy Medical Products, 2021-2030
  • 11.5. Cell Therapy Packaging Services Market, 2021-2030: Distribution by Package Engineering Design
    • 11.5.1. Cell Therapy Packaging Services Market for Primary Packaging, 2021-2030
    • 11.5.2. Cell Therapy Packaging Services Market for Secondary Packaging, 2021-2030
  • 11.6. Cell Therapy Packaging Services Market, 2021-2030: Distribution by Scale of Operation
    • 11.6.1. Cell Therapy Packaging Services Market for Clinical Scale Operations, 2021-2030
    • 11.6.2. Cell Therapy Packaging Services Market for Commercial Scale Operations, 2021-2030
  • 11.7. Cell Therapy Packaging Services Market, 2021-2030: Distribution by Geographical Regions
    • 11.7.1. Cell Therapy Packaging Services Market in North America, 2021-2030
    • 11.7.2. Cell Therapy Packaging Services Market in Europe, 2021-2030
    • 11.7.3. Cell Therapy Packaging Services Market in Asia Pacific, 2021-2030
    • 11.7.4. Cell Therapy Packaging Services Market in Rest of the World, 2021-2030

12. CONCLUDING REMARKS

  • 12.1. Chapter Overview

13. APPENDIX 1: TABULATED DATA

14. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

List Of Figures

  • Figure 3.1 Traditional Aseptic Pharmaceutical Filling
  • Figure 3.2 Advantages of Pharmaceutical Packaging
  • Figure 3.3 Types of Pharmaceutical Packaging
  • Figure 3.4 Packaging Containers for Cell Therapies
  • Figure 3.5 Challenging aspects of Cell Therapy Packaging
  • Figure 4.1 Cell Therapy Packaging Service Providers: Distribution by Year of Establishment
  • Figure 4.2 Cell Therapy Packaging Service Providers: Distribution by Company Size
  • Figure 4.3 Cell Therapy Packaging Service Providers: Distribution by Location of Headquarters
  • Figure 4.4 Cell Therapy Packaging Service Providers: Distribution by Package Engineering Design
  • Figure 4.5 Cell Therapy Packaging Service Providers: Distribution by Type of Packaging
  • Figure 4.6 Cell Therapy Packaging Service Providers: Distribution by Packaging Material
  • Figure 4.7 Cell Therapy Packaging Service Providers: Distribution by Type of Packaging and Packaging Material
  • Figure 4.8 Cell Therapy Packaging Service Providers: Distribution by Type of Passive System Used
  • Figure 4.9 Cell Therapy Packaging Service Providers: Distribution by Temperature Ranges Supported
  • Figure 4.10 Cell Therapy Packaging Service Providers: Distribution by Type of Packaging, Packaging Material and Temperature Ranges Supported
  • Figure 4.11 Cell Therapy Packaging Service Providers: Distribution by Type of Cells Handled
  • Figure 4.12 Cell Therapy Packaging Service Providers: Distribution by Type of Additional Service(s) Offered
  • Figure 4.13 Logo landscape: Key Players Offering Additional Services
  • Figure 5.1 Cell Therapy Packaging Products: Distribution by Type of Packaging Container
  • Figure 5.2 Cell Therapy Packaging Products: Distribution by Container Fabrication Material
  • Figure 5.3 Cell Therapy Packaging Products: Distribution by Type of Packaging Container and Container Fabrication Material
  • Figure 5.4 Cell Therapy Packaging Products: Distribution by Storage Temperature Conditions
  • Figure 5.5 Cell Therapy Packaging Products: Distribution by Type of Packaging Container and Storage Temperature Conditions
  • Figure 5.6 Cell Therapy Packaging Products: Distribution by Type of Cells Packed
  • Figure 5.7 Cell Therapy Packaging Products: Distribution by Usability of Container
  • Figure 5.8 Cell Therapy Packaging Product Providers: Distribution by Year of Establishment
  • Figure 5.9 Cell Therapy Packaging Product Providers: Distribution by Company Size
  • Figure 5.10 Cell Therapy Packaging Product Providers: Distribution by Location of Headquarters
  • Figure 5.11 Key Players: Analysis by Number of Cell Therapy Packaging Products
  • Figure 6.1 Almac: Cell Therapy Service Portfolio
  • Figure 6.2 Catalent Pharma Solutions: Cell Therapy Service Portfolio
  • Figure 6.3 Cryoport Systems: Cell Therapy Service Portfolio
  • Figure 6.4 Yourway: Cell Therapy Service Portfolio
  • Figure 7.1 Company Competitiveness Analysis: Cell Therapy Packaging Service Providers based in North America
  • Figure 7.2 Company Competitiveness Analysis: Cell Therapy Packaging Service Providers based in Europe and Asia-Pacific
  • Figure 8.1 Partnerships and Collaborations: Cumulative Year-wise Trend, 2016-2021
  • Figure 8.2 Partnerships and Collaborations: Distribution by Type of Partnership
  • Figure 8.3 Partnerships and Collaborations: Distribution by Year and Type of Partnership, 2016-2021 (till April)
  • Figure 8.4 Partnerships and Collaborations: Distribution by Purpose of Partnership
  • Figure 8.5 Partnerships and Collaborations: Distribution by Type of Service(s) Covered
  • Figure 8.6 Most Active Players: Distribution by Number of Partnerships
  • Figure 8.7 Partnerships and Collaborations: Distribution by Location of Parent Company
  • Figure 8.8 Partnerships and Collaborations: Distribution by Location of Partner Company
  • Figure 8.9 Partnerships and Collaborations: Intercontinental and Intracontinental Agreements
  • Figure 10.1 Cell Therapy Manufacturers: Distribution by Year of Establishment
  • Figure 10.2 Cell Therapy Manufacturers: Distribution by Company Size
  • Figure 10.3 Cell Therapy Manufacturers: Distribution by Location of Headquarters
  • Figure 10.4 Cell Therapy Manufacturers: Distribution by Location of Headquarters (Country Wise)
  • Figure 10.5 Cell Therapy Manufacturers: Distribution by Location of Manufacturing Facility (Region-wise)
  • Figure 10.6 Cell Therapy Manufacturers: Distribution by Location of Manufacturing Facility (Country-wise)
  • Figure 10.7 Cell Therapy Manufacturers: Distribution by Type of Cells Manufactured
  • Figure 10.8 Cell Therapy Manufacturers: Distribution by Type of Manufacturers
  • Figure 10.9 Cell Therapy Manufacturers: Distribution by Source of Cells
  • Figure 10.10 Cell Therapy Manufacturers: Distribution by Scale of Operation
  • Figure 10.11 Cell Therapy Manufacturers: Distribution by Manufacturing Capabilities / Services
  • Figure 11.1 Global Cell Therapy Packaging Services Market, 2021-2030 (USD Million)
  • Figure 11.2 Cell Therapy Packaging Services Market for T -Cell based Therapies, 2021-2030 (USD Million)
  • Figure 11.3 Cell Therapy Packaging Services Market for Dendritic Cell Vaccines, 2021-2030 (USD Million)
  • Figure 11.4 Cell Therapy Packaging Services Market for Stem Cell Therapies, 2021-2030 (USD Million)
  • Figure 11.5 Cell Therapy Packaging Services Market for NK Cell Therapies, 2021-2030 (USD Million)
  • Figure 11.6 Cell Therapy Packaging Services Market for Other Advanced Therapy Medicinal Products, 2021-2030 (USD Million)
  • Figure 11.7 Cell Therapy Packaging Services Market for Primary Packaging, 2021-2030 (USD Million)
  • Figure 11.8 Cell Therapy Packaging Services Market for Secondary Packaging, 2021-2030 (USD Million)
  • Figure 11.9 Cell Therapy Packaging Services Market for Clinical Scale Operations, 2021-2030 (USD Million)
  • Figure 11.10 Cell Therapy Packaging Services Market for Commercial Scale Operations, 2021-2030 (USD Million)
  • Figure 11.11 Cell Therapy Packaging Services Market in North America, 2021-2030 (USD Million)
  • Figure 11.12 Cell Therapy Packaging Services Market in Europe, 2021-2030 (USD Million)
  • Figure 11.13 Cell Therapy Packaging Services Market in Asia- Pacific, 2021-2030 (USD Million)
  • Figure 11.14 Cell Therapy Packaging Services Market in Rest of the World, 2021-2030 (USD Million)
  • Figure 12.1 Conclusion

List Of Tables

  • Table 4.1 Cell Therapy Packaging Service Providers
  • Table 4.2 Cell Therapy Packaging Service Providers: Information on Package Engineering Design, Type of Packaging, Packaging Material and Type of Passive System Used
  • Table 4.3 Cell Therapy Packaging Service Providers: Information on Temperature Ranges Supported and Type of Cells Handled
  • Table 4.4 Cell Therapy Packaging Service Providers: Information on Additional Services Offered
  • Table 5.1 Cell Therapy Packaging Products: Information on Type of Packaging Container and Container Fabrication Material
  • Table 5.2 Cell Therapy Packaging Products: Information on Storage Temperature Conditions, Packaging Volume, Type of Cells Stored and Availability of Single-use Product
  • Table 5.3 Cell Therapy Packaging Product Providers: List of Industry Players
  • Table 6.1 Cell Therapy Packaging Service and Product Providers: List of Companies Profiled
  • Table 6.2 Almac: Company Snapshot
  • Table 6.3 Almac: Recent Developments and Future Outlook
  • Table 6.4 Cryoport Systems: Company Snapshot
  • Table 6.5 Cryoport Systems: Recent Developments and Future Outlook
  • Table 6.6 Catalent Pharma Solutions: Company Snapshot
  • Table 6.7 Catalent Pharma Solutions: Recent Developments and Future Outlook
  • Table 6.8 Yourway: Company Snapshot
  • Table 6.9 Lufthansa Cargo: Company Snapshot
  • Table 6.10 Lufthansa Cargo: Product Portfolio
  • Table 6.11 Lufthansa Cargo: Recent Developments and Future Outlook
  • Table 6.12 Saint-Gobain Life Sciences: Company Snapshot
  • Table 6.13 Saint-Gobain Life Sciences: Product Portfolio
  • Table 6.14 Thermo Fisher Scientific: Company Snapshot
  • Table 6.15 Thermo Fisher Scientific: Product Portfolio
  • Table 6.16 Thermo Fisher Scientific: Recent Developments and Future Outlook
  • Table 6.17 West Pharmaceutical Services: Company Snapshot
  • Table 6.18 West Pharmaceutical Services: Product Portfolio
  • Table 6.19 West Pharmaceutical Services: Recent Developments and Future Outlook
  • Table 7.1 Cell Therapy Packaging: List of Partnerships and Collaborations, 2016-2021
  • Table 7.2 Partnerships and Collaborations: Information on Type of Service(s) Covered
  • Table 9.1 Most Likely Partners for Cell Therapy Packaging Product and Service Providers in North America
  • Table 9.2 Likely Partners for Cell Therapy Packaging Product and Service Providers in North America
  • Table 9.3 Less Likely Partners for Cell Therapy Packaging Product and Service Providers in North America
  • Table 9.4 Most Likely Partners for Cell Therapy Packaging Product and Service Providers in Europe
  • Table 9.5 Likely Partners for Cell Therapy Packaging Product and Service Providers in Europe
  • Table 9.6 Less Likely Partners for Cell Therapy Packaging Product and Service Providers in Europe
  • Table 9.7 Most Likely Partners for Cell Therapy Packaging Product and Service Providers in Asia Pacific and RoW
  • Table 9.8 Likely Partners for Cell Therapy Packaging Product and Service Providers in Asia Pacific and RoW
  • Table 9.9 Less Likely Partners for Cell Therapy Packaging Product and Service Providers in Asia Pacific and RoW
  • Table 10.1 Cell Therapy Manufacturers: List of Industry Players
  • Table 10.2 Cell Therapy Manufacturers: Information on Type of Cells Manufactured
  • Table 10.3 Cell Therapy Manufacturers: Information on Source of Cells
  • Table 10.4 Cell Therapy Manufacturers: Information on Scale of Operation
  • Table 10.5 Cell Therapy Manufacturers: Information on Type of Manufacturing Capabilities / Services
  • Table 13.1 Cell Therapy Packaging Service Providers: Distribution by Year of Establishment
  • Table 13.2 Cell Therapy Packaging Service Providers: Distribution by Company Size
  • Table 13.3 Cell Therapy Packaging Service Providers: Distribution by Location of Headquarters
  • Table 13.4 Cell Therapy Packaging Service Providers: Distribution by Package Engineering Design
  • Table 13.5 Cell Therapy Packaging Service Providers: Distribution by Type of Packaging
  • Table 13.6 Cell Therapy Packaging Service Providers: Distribution by Packaging Material
  • Table 13.7 Cell Therapy Packaging Service Providers: Distribution by Type of Packaging and Packaging Material
  • Table 13.8 Cell Therapy Packaging Service Providers: Distribution by Type of Passive System Used
  • Table 13.9 Cell Therapy Packaging Service Providers: Distribution by Temperature Ranges Supported
  • Table 13.10 Cell Therapy Packaging Service Providers: Distribution by Type of Packaging, Packaging Material and Temperature Ranges Supported
  • Table 13.11 Cell Therapy Packaging Service Providers: Distribution by Type of Cells Handled
  • Table 13.12 Cell Therapy Packaging Service Providers: Distribution by Type of Additional Services Offered
  • Table 13.13 Cell Therapy Packaging Products: Distribution by Type of Packaging Container
  • Table 13.14 Cell Therapy Packaging Products: Distribution by Container Fabrication Material
  • Table 13.15 Cell Therapy Packaging Products: Distribution by Type of Packaging Container and Container Fabrication Material
  • Table 13.16 Cell Therapy Packaging Products: Distribution by Storage Temperature Conditions
  • Table 13.17 Cell Therapy Packaging Products: Distribution by Type of Container and Storage Temperature Conditions
  • Table 13.18 Cell Therapy Packaging Products: Distribution by Type of Cells Packed
  • Table 13.19 Cell Therapy Packaging Products: Distribution by Usability of Container
  • Table 13.20 Cell Therapy Packaging Product Providers: Distribution by Year of Establishment
  • Table 13.21 Cell Therapy Packaging Product Providers: Distribution by Company Size
  • Table 13.22 Cell Therapy Packaging Product Providers: Distribution by Location of Headquarters
  • Table 13.23 Partnerships and Collaborations: Cumulative Year-wise Trend, 2016-2021 (till April)
  • Table 13.24 Partnerships and Collaborations: Distribution by Type of Partnership
  • Table 13.25 Partnerships and Collaborations: Distribution by Year and Type of Partnership, 2016-2021 (till April)
  • Table 13.26 Partnerships and Collaborations: Distribution by Purpose of Partnerships
  • Table 13.27 Partnerships and Collaborations: Distribution by Type of Service(s) Covered
  • Table 13.28 Most Active Players: Distribution by Number of Partnerships
  • Table 13.29 Partnerships and Collaborations: Distribution by Location of Parent Company
  • Table 13.30 Partnerships and Collaborations: Distribution by Location of Partner Company
  • Table 13.31 Partnerships and Collaborations: Distribution by Intercontinental and Intracontinental Partnerships
  • Table 13.32 Cell Therapy Manufacturers: Distribution by Year of Establishment
  • Table 13.33 Cell Therapy Manufacturers: Distribution by Company Size
  • Table 13.34 Cell Therapy Manufacturers: Distribution by Location of Headquarters
  • Table 13.35 Cell Therapy Manufacturers: Distribution by Location of Headquarters (Country Wise)
  • Table 13.36 Cell Therapy Manufacturers: Distribution by Location of Manufacturing Facility (Region-wise)
  • Table 13.37 Cell Therapy Manufacturers: Distribution by Location of Manufacturing Facility (Country-wise)
  • Table 13.38 Cell Therapy Manufacturers: Distribution by Type of Cells Manufactured
  • Table 13.39 Cell Therapy Manufacturers: Distribution by Type of Manufacturers
  • Table 13.40 Cell Therapy Manufacturers: Distribution by Source of Cells
  • Table 13.41 Cell Therapy Manufacturers: Distribution by Scale of Operation
  • Table 13.42 Cell Therapy Manufacturers: Distribution by Manufacturing Capabilities / Services
  • Table 13.43 Global Cell Therapy Packaging Services Market, 2021-2030 (USD Million)
  • Table 13.44 Cell Therapy Packaging Services Market for T- Cell based Therapies, 2021-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 13.45 Cell Therapy Packaging Services Market for Dendritic Cell Vaccines, 2021-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 13.46 Cell Therapy Packaging Services Market for Stem Cell Therapies, 2021-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 13.47 Cell Therapy Packaging Services Market for NK Cell Therapies, 2021-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 13.48 Cell Therapy Packaging Services Market for Other Advanced Therapy Medicinal Products, 2021-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 13.49 Cell Therapy Packaging Services Market for Primary Packaging, 2021-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 13.50 Cell Therapy Packaging Services Market for Secondary Packaging, 2021-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 13.51 Cell Therapy Packaging Services Market for Clinical Scale Operations, 2021-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 13.52 Cell Therapy Packaging Services Market for Commercial Scale Operations, 2021-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 13.53 Cell Therapy Packaging Services Market in North America, 2021-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 13.54 Cell Therapy Packaging Services Market in Europe, 2021-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 13.55 Cell Therapy Packaging Services Market in Asia Pacific, 2021-2030: Conservative, Base and Optimistic Scenarios (USD Million)
  • Table 13.56 Cell Therapy Packaging Services Market in Rest of the World, 2021-2030: Conservative, Base and Optimistic Scenarios (USD Million)

List Of Companies

  • 1. 3P Biopharmaceuticals
  • 2. A2 Biotherapeutics
  • 3. A4P
  • 4. AbClon
  • 5. Abeona Therapeutics
  • 6. AccuResearch Korea
  • 7. Achilles Therapeutics
  • 8. Adaptimmune Therapeutics
  • 9. Adicet Bio
  • 10. ADVATIS
  • 11. Advent Biologics
  • 12. Aegle Therapeutics
  • 13. Aeon Therapeutics
  • 14. AffyImmune Therapeutics
  • 15. AGC Biologics
  • 16. AgenTus Therapeutics
  • 17. Akron Biologics
  • 18. Alitalia
  • 19. Allele Biotechnology and Pharmaceuticals
  • 20. AlLife Medicine
  • 21. Allogene Therapeutics
  • 22. Almac
  • 23. Almog
  • 24. Altaco XXI
  • 25. Angiocrine Bioscience
  • 26. Anterogen
  • 27. apceth Biopharma (acquired by Hitachi Chemical)
  • 28. Arbele
  • 29. Arcellx
  • 30. Aseptic Technologies
  • 31. Aspire Health Science
  • 32. Astellas Pharma
  • 33. Atara Biotherapeutics
  • 34. Athersys
  • 35. Atlantis Bioscience
  • 36. Aurora Biopharma
  • 37. Asutrianova
  • 38. Autolus Therapeutics
  • 39. Axis Biotec
  • 40. Azidus
  • 41. Baylx
  • 42. Beijing Biohealthcare Biotechnology
  • 43. Beijing Doing Biomedical
  • 44. Beijing Sanwater Biological Technology
  • 45. Bellicum Pharmaceuticals
  • 46. BHI Therapeutic Sciences
  • 47. Bio Elpida
  • 48. Biocair
  • 49. BioCardia
  • 50. Bioceltech Therapeutics
  • 51. BioCentriq
  • 52. BioInno Bioscience
  • 53. Bioinova
  • 54. BioNTech Manufacturing
  • 55. Bioquark
  • 56. BioRestorative Therapies
  • 57. Biotech & Pharma Logistics
  • 58. Biowy
  • 59. bluebird bio
  • 60. BlueRock Therapeutics (acquired by Bayer)
  • 61. Bone Therapeutics
  • 62. BrainStorm Cell Therapeutics
  • 63. Bristol Myers Squibb
  • 64. Brooks Life Sciences
  • 65. Bukwang Pharmaceutical
  • 66. Caladrius Biosciences
  • 67. Capricor Therapeutics
  • 68. Carina Biotech
  • 69. CARsgen Therapeutics
  • 70. CAR-T (Shanghai) Biotechnology
  • 71. Cartesian Therapeutics
  • 72. Cartherics
  • 73. Catalent Biologics
  • 74. Celgene
  • 75. Celixir
  • 76. Cell and Gene Therapy Catapult
  • 77. Cell Medica
  • 78. Cell Therapies
  • 79. CellBios
  • 80. Cell-Easy
  • 81. Cellectis
  • 82. Cellerant Therapeutics
  • 83. Cellex
  • 84. Cellin Technologies
  • 85. CellMP
  • 86. CellProtect Nordic Pharmaceuticals
  • 87. CellProthera
  • 88. Cellular Biomedicine
  • 89. Celonic
  • 90. Celularity
  • 91. Celyad Oncology
  • 92. CENTOGENE
  • 93. Cesca Therapeutics
  • 94. CHA Biotech
  • 95. Chiesi
  • 96. China Immunotech (Beijing) Biotechnology
  • 97. China Regenerative Medicine
  • 98. Chongqing Precision Biotech
  • 99. Clean Cells
  • 100. Co.don
  • 101. Cognate BioServices (acquired by Charles River Laboratories)
  • 102. CoImmune
  • 103. ColdStash
  • 104. Cook MyoSite
  • 105. Cook Pharmica
  • 106. CORESTEM
  • 107. Creative Biolabs
  • 108. CRISPR Therapeutics
  • 109. Critical Transport Solutions Australia
  • 110. Cryo-Cell
  • 111. CryoGene
  • 112. CRYOPDP (acquired by Cryoport)
  • 113. Cryoport
  • 114. CSafe Global
  • 115. Cynata Therapeutics
  • 116. Cytiva
  • 117. CytoMed Therapeutics
  • 118. Cytopeutics
  • 119. Cytovac
  • 120. Dendreon Pharmaceuticals
  • 121. DiscGenics
  • 122. DWK Life Sciences
  • 123. EHL Bio
  • 124. ElevateBio
  • 125. Eli Lilly
  • 126. EpiBone
  • 127. Eutilex
  • 128. Ever Supreme Bio Technology
  • 129. EVERSANA
  • 130. EUMA Biotech
  • 131. Fate Therapeutics
  • 132. Ferrer Internacional
  • 133. Fibrocell Science
  • 134. Formula Pharmaceuticals
  • 135. Fortress Biotech
  • 136. Fosun Kite Biotechnology
  • 137. Froceth
  • 138. FUJIFILM Irvine Scientific
  • 139. Gamida Cell
  • 140. GC Cell
  • 141. GE Healthcare
  • 142. GenCure
  • 143. Genenta Science
  • 144. GenIbet Biopharmaceuticals
  • 145. Genus Oncology
  • 146. GigaGen
  • 147. GlaxoSmithKline
  • 148. Global Cell Med
  • 149. Glycostem Therapeutics
  • 150. Gracell Biotechnologies
  • 151. GC Pharma
  • 152. Greiner Bio-One
  • 153. Gwo xi Stem Cell
  • 154. Hebei Newtherapy BIo-Pharma technology
  • 155. Hebei Senlang Biotechnology
  • 156. Helix BioPharma
  • 157. HemaCare
  • 158. Hemostemix
  • 159. Histocell
  • 160. Hitachi Chemical
  • 161. Holostem Terapie Avanzate
  • 162. Hope Biosciences
  • 163. Horizon Discovery
  • 164. Hrain Biotechnology
  • 165. iCell Gene Therapeutics
  • 166. Icell Kealex Therapeutics
  • 167. ICS
  • 168. ilaya
  • 169. Immatics
  • 170. Immetacyte
  • 171. Immune Therapeutics
  • 172. Immuneel Therapeutics
  • 173. Immunocore
  • 174. Immunovative Therapies
  • 175. IncoCell Tianjin
  • 176. INNOFORCE
  • 177. Innovative Cellular Therapeutics
  • 178. Instant Systems
  • 179. Instil Bio
  • 180. Intellia Therapeutics
  • 181. International Stem Cell
  • 182. Invectys
  • 183. Iovance Biotherapeutics
  • 184. Ixaka
  • 185. Janssen
  • 186. Japan Regenerative Medicine
  • 187. Japan Tissue Engineering
  • 188. jCyte
  • 189. Jiuzhitang Maker Cell Technology
  • 190. Juno Therapeutics
  • 191. Juventas Cell Therapy
  • 192. JW Therapeutics
  • 193. JW CreaGene
  • 194. Kadimastem
  • 195. KAEDI
  • 196. Kangstem Biotech
  • 197. KBI Biopharma
  • 198. Kiadis Pharma
  • 199. Kite Pharma
  • 200. KLSMC Stem Cells
  • 201. KSQ Therapeutics
  • 202. K-Stem Cell
  • 203. Kymanox
  • 204. Lai
  • 205. LATAM Cargo
  • 206. Legend Biotech
  • 207. Leucid Bio
  • 208. LifeCell
  • 209. Lineage Cell Therapeutics
  • 210. Lion TCR
  • 211. Living Pharma
  • 212. Longeveron
  • 213. Lonza
  • 214. Lufthansa Cargo
  • 215. Lykan Bioscience
  • 216. Macopharma
  • 217. Magellan Biologicals
  • 218. Magenta Therapeutics
  • 219. Marken
  • 220. Marker Therapeutics
  • 221. McKesson
  • 222. Med Cell Bahamas
  • 223. Medeor Therapeutics
  • 224. Medigene
  • 225. MEDINET
  • 226. MEDIPOST
  • 227. Medisix Therapeutics
  • 228. Melbourne Stem Cell Centre
  • 229. Meridigen Biotech
  • 230. Mesoblast
  • 231. Miltenyi Biomedicine
  • 232. Minaris Regenerative Medicine
  • 233. Minerva Biotechnologies
  • 234. MingJu Therapeutics
  • 235. Minovia Therapeutics
  • 236. MNX Global Logistics
  • 237. MolMed
  • 238. Müller + Müller (acquired by DWK Life Sciences)
  • 239. Multimmune
  • 240. Mustang Bio
  • 241. MVE Biological Solutions
  • 242. Nanjing Bioheng Biotech
  • 243. NanoCool
  • 244. NantKwest
  • 245. Nature Cell
  • 246. NeuroGeneration
  • 247. NextCell Pharma
  • 248. Nikon CeLL Innovation
  • 249. Nipro Europe Group Companies
  • 250. Nkarta
  • 251. NKMax America
  • 252. Nohla Therapeutics
  • 253. Noile-Immune Biotech
  • 254. Noray Biosciences Group
  • 255. Novadip Biosciences
  • 256. Novartis
  • 257. Novex Innovations
  • 258. NuVasive
  • 259. Obsidian Therapeutics
  • 260. Ology Bioservices
  • 261. Orca Bio
  • 262. Orchard Therapeutics
  • 263. OrganaBio
  • 264. OriGen Biomedical
  • 265. Orthofix
  • 266. Osiris Therapeutics
  • 267. Oxford Biomedica
  • 268. PackGene Biotech
  • 269. PACT Pharma
  • 270. Parexel
  • 271. Patheon
  • 272. PeproMene Bio
  • 273. Personalized Stem Cells
  • 274. PersonGen BioTherapeutics
  • 275. PharmaBio
  • 276. Pharmicell
  • 277. Phio Pharmaceuticals
  • 278. Pluristem Therapeutics
  • 279. Plus Therapeutics
  • 280. Poseida Therapeutics
  • 281. Precigen
  • 282. Precision BioSciences
  • 283. Promethera Biosciences
  • 284. Protheragen
  • 285. Provia Laboratories
  • 286. Q Therapeutics
  • 287. Quick
  • 288. R3 Stem Cell
  • 289. Regeneus
  • 290. Regenexx
  • 291. Reliance Life Sciences
  • 292. ReNeuron
  • 293. Riordan Technologies
  • 294. Riyadh Pharma
  • 295. ROHTO Pharmaceutical
  • 296. Roslin Cell Therapies
  • 297. Roylance Pharma
  • 298. RTI Surgical
  • 299. Rubius Therapeutics
  • 300. S.Biomedics
  • 301. SABZ Biomedicals
  • 302. Saint-Gobain
  • 303. Salvat
  • 304. SanBio
  • 305. Sangamo Therapeutics
  • 306. SAVSU Technologies (acquired by BioLife Solutions)
  • 307. SCHOTT
  • 308. Sclnow Biotechnology
  • 309. SCM Lifescience
  • 310. Seattle Genetics
  • 311. Seneca Biopharma
  • 312. Sensei Biotherapeutics
  • 313. Sentien Biotechnologies
  • 314. Sequel Logistics
  • 315. Servier
  • 316. Sexton Biotechnologies
  • 317. SGD Pharma
  • 318. Shandong Qilu Stem Cells Engineering
  • 319. Shanghai Biomed-Union Biotechnology
  • 320. Shanghai GeneChem
  • 321. Shanghai iCELL Biotechnology
  • 322. Shanghai Longyao Biotechnology
  • 323. Shenzhen Binde Biotechnology
  • 324. Shenzhen Hornetcorn Biotechnology
  • 325. Sinobioway Cell Therapy
  • 326. SiO2 Materials Science
  • 327. SMT Bio
  • 328. Sorrento Therapeutics
  • 329. SOTIO
  • 330. S-RACMO
  • 331. Stem Cell Medicine
  • 332. Stem Med
  • 333. STEMCELL Technologies
  • 334. Stemedica Cell Technologies
  • 335. Steminent Biotherapeutics
  • 336. Stemmatters
  • 337. Stempeutics Research
  • 338. Stryker
  • 339. Sumitomo Dainippon Pharma
  • 340. Suzuken
  • 341. Swiss Medica XXI Century
  • 342. Swiss WorldCargo
  • 343. Tactiva Therapeutics
  • 344. Taiwan Bio Therapeutics
  • 345. Takara Bio
  • 346. Takeda Pharmaceutical
  • 347. Talaris Therapeutics
  • 348. Targazyme
  • 349. TC BioPharm
  • 350. TCR2 Therapeutics
  • 351. Technoflex
  • 352. Teneobio
  • 353. Terumo
  • 354. Tessa Therapeutics
  • 355. The Emmes Company
  • 356. Thermo Fisher Scientific
  • 357. Tianhe Stem Cell Biotechnologies
  • 358. Tianjin Ever Union Biotechnology
  • 359. Tianjin Mycure Medical Technology
  • 360. Tianjin Weikai Biological Engineering
  • 361. TICEBA
  • 362. TiGenix
  • 363. TILT Biotherapeutics
  • 364. time:matters
  • 365. Timmune Biotech
  • 366. Tissue Solutions
  • 367. Tmunity Therapeutics
  • 368. TPP Techno Plastic Products
  • 369. TrakCel
  • 370. TreeFrog Therapeutics
  • 371. Tscan Therapeutics
  • 372. TVAX Biomedical
  • 373. U.S. Stem Cell
  • 374. Ucardi Biomedical Technology
  • 375. United Cargo
  • 376. United Parcel Services (UPS)
  • 377. United Therapeutics
  • 378. University College of London
  • 379. Unum Therapeutics
  • 380. UWELL Biopharma
  • 381. va-Q-tec
  • 382. VcanBio Center for Translational Biotechnology
  • 383. Vericel
  • 384. VetStem Biopharma
  • 385. ViaCyte
  • 386. Vineti
  • 387. Viscofan BioEngineering
  • 388. Vitalant
  • 389. Waisman Biomanufacturing
  • 390. Wellington Zhaotai Therapies
  • 391. West
  • 392. West Biotherapy
  • 393. World Courier
  • 394. Wugen
  • 395. WuXi Advanced Therapies
  • 396. Xiangxue Life Sciences
  • 397. Yourway
  • 398. Zelluna Immunotherapy
  • 399. Zumutor Biologics